Newsfeeds - Spark Newswire

2 minute read

Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January

Today, 8:42 PM

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.51% to 33,881.69 while the NASDAQ fell 1.32% to 12,039.79. The S&P 500 also fell, dropping, 0.98% to 4,138.89.

BBAI

1 minute read

BTIG Maintains Buy on MDxHealth, Raises Price Target to $15

By Benzinga Newsdesk

Today, 8:42 PM

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and raises the price target from $13 to $15.

MDXH

2 minute read

Is A Surprise Coming For MDxHealth (MDXH) This Earnings Season?

By Zacks

Today, 8:42 PM

Investors are always looking for stocks that are poised to beat at earnings season and MDxHealth SA (NASDAQ: MDXH) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

MDXH

1 minute read

Mdxhealth Acquires Oncotype DX GPS Prostate Cancer Business From Exact Sciences For Aggregate Purchase Price Of Up To $100M

By Bill Haddad

Today, 8:42 PM

Under the terms of the asset purchase agreement, mdxhealth acquired the Oncotype DX GPS prostate cancer business of Exact Sciences for an aggregate purchase price of up to $100 million, of which an amount of $25 million

EXAS

5 minute read

66 Biggest Movers From Friday

By Lisa Levin

Today, 8:42 PM

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.

AEMD

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 8:42 PM

ATHX

1 minute read

BTIG Initiates Coverage On MDxHealth with Buy Rating, Announces Price Target of $15

By Benzinga Newsdesk

Today, 8:42 PM

BTIG analyst Mark Massaro initiates coverage on MDxHealth (NASDAQ:MDXH) with a Buy rating and announces Price Target of $15.

MDXH

1 minute read

Piper Sandler Initiates Coverage On MDxHealth with Overweight Rating, Announces Price Target of $15

By Benzinga Newsdesk

Today, 8:42 PM

Piper Sandler analyst Jason Bednar initiates coverage on MDxHealth (NASDAQ:MDXH) with a Overweight rating and announces Price Target of $15.

MDXH

2 minute read

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week

By Shanthi Rexaline

Today, 8:42 PM

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week.

AADI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 8:42 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT